These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546
771 results:

  • 1. Comparison of insulinoma-associated protein 1 (INSM1) with traditional neuroendocrine markers in gastrointestinal and pancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNENs).
    Gao R; Zhang X; Chen X; Lin Y; Jin L; Zheng H; Yu X
    Diagn Pathol; 2024 Oct; 19(1):144. PubMed ID: 39472993
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Molecular markers for pediatric low-grade glioma.
    Levine AB; Hawkins CE
    Childs Nerv Syst; 2024 Oct; 40(10):3223-3228. PubMed ID: 39379532
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Case Series:
    Cortez BN; Kuo MJM; Jha A; Patel M; Carrasquillo JA; Prodanov T; Charles KM; Talvacchio S; Derkyi A; Lin FI; Taïeb D; Del Rivero J; Pacak K
    Front Endocrinol (Lausanne); 2024; 15():1399847. PubMed ID: 39351526
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Navigating the diagnostic gray zone: a challenging case of pancreatic high-grade neuroendocrine neoplasm.
    Mullen B; Sy AL; Dias Goncalves P; Zhang ML
    Diagn Pathol; 2024 Sep; 19(1):123. PubMed ID: 39267076
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Clinicopathological and molecular characteristics of pediatric gliomas: analysis of 111 cases].
    Xu H; Niu HL; Wang FH; Xu XK; Wang W; Yuan L; Chen K; Gao Q; Li LP; Xia JQ; Guo ZM
    Zhonghua Bing Li Xue Za Zhi; 2024 Sep; 53(9):922-928. PubMed ID: 39231745
    [No Abstract]    [Full Text] [Related]  

  • 6. Radiogenomic profiling of global DNA methylation associated with molecular phenotypes and immune features in glioma.
    Zhuang Z; Lin J; Wan Z; Weng J; Yuan Z; Xie Y; Liu Z; Xie P; Mao S; Wang Z; Wang X; Huang M; Luo Y; Yu H
    BMC Med; 2024 Sep; 22(1):352. PubMed ID: 39218882
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Clinicopathological Features of the Solitary Subependymal Giant cell Astrocytoma: A Systematic Review.
    Piña-Ballantyne SA; Espinosa-Aguilar EJ; Calderón-Garcidueñas AL
    Neurol India; 2024 Jul; 72(4):708-717. PubMed ID: 39216021
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparative genomic landscape of lower-grade glioma and glioblastoma.
    Sun X; Jia Q; Li K; Tian C; Yi L; Yan L; Zheng J; Jia X; Gu M
    PLoS One; 2024; 19(8):e0309536. PubMed ID: 39208202
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pediatric Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of the Literature on Biological Features and New Therapeutic Strategies.
    Bonada M; Pittarello M; De Fazio E; Gans A; Alimonti P; Slika H; Legnani F; Di Meco F; Tyler B
    Genes (Basel); 2024 Aug; 15(8):. PubMed ID: 39202398
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. MEN1/DAXX/atrx mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy.
    Gujarathi R; Abou Azar S; Tobias J; Polite BN; Setia N; Feinberg N; Appelbaum DE; Keutgen XM; Liao CY
    Endocr Relat Cancer; 2024 Nov; 31(11):. PubMed ID: 39093924
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Deep learning-based IDH1 gene mutation prediction using histopathological imaging and clinical data.
    Nakagaki R; Debsarkar SS; Kawanaka H; Aronow BJ; Prasath VBS
    Comput Biol Med; 2024 Sep; 179():108902. PubMed ID: 39038392
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomas.
    Jansen P; Galetzka W; Lodde GC; Standl F; Zaremba A; Herbst R; Terheyden P; Utikal J; Pföhler C; Ulrich J; Kreuter A; Mohr P; Gutzmer R; Meier F; Dippel E; Weichenthal M; Placke JM; Landsberg J; Möller I; Sucker A; Paschen A; Hadaschik E; Zimmer L; Livingstone E; Schadendorf D; Ugurel S; Stang A; Griewank KG
    Eur J Cancer; 2024 Sep; 208():114208. PubMed ID: 39018633
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location.
    Guidara S; Seyve A; Poncet D; Leonce C; Bringuier PP; McLeer A; Sturm D; Cartalat S; Picart T; Ferrari A; Hench J; Frank S; Meyronet D; Ducray F; Barritault M
    J Neurooncol; 2024 Sep; 169(2):391-398. PubMed ID: 38937309
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Evaluation of Microvascular Density in Glioblastomas in Relation to p53 and Ki67 Immunoexpression.
    Sipos TC; Kövecsi A; Kocsis L; Nagy-Bota M; Pap Z
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928515
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Loss of atrx and DAXX in pancreatic neuroendocrine tumors: Association with recurrence risk, cellular phenotype, and heterogeneity.
    Yasunaga Y; Tanaka M; Arita J; Hasegawa K; Ushiku T
    Hum Pathol; 2024 Aug; 150():51-57. PubMed ID: 38909708
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Multi-pool chemical exchange saturation transfer MRI in glioma grading, molecular subtyping and evaluating tumor proliferation.
    Zhu H; Li Y; Ding Y; Liu Y; Shen N; Xie Y; Yan S; Liu D; Zhang X; Li L; Zhu W
    J Neurooncol; 2024 Sep; 169(2):287-297. PubMed ID: 38874844
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Well-differentiated G1 and G2 pancreatic neuroendocrine tumors: a meta-analysis of published expanded DNA sequencing data.
    Andersen KØ; Detlefsen S; Brusgaard K; Christesen HT
    Front Endocrinol (Lausanne); 2024; 15():1351624. PubMed ID: 38868744
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A paradigm shift in understanding vulvovaginal melanoma as a distinct tumor type compared with cutaneous melanoma.
    Wilhite AM; Wu S; Xiu J; Gibney GT; Phung T; In GK; Herzog TJ; Khabele D; Erickson BK; Brown J; Rocconi RP; Pierce JY; Scalici JM; Jones NL
    Gynecol Oncol; 2024 Sep; 188():13-21. PubMed ID: 38861917
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Disease relapse in relation to lymph node sampling in lung carcinoid patients.
    Moonen L; Derks JL; Hillen LM; van Suylen RJ; den Bakker MA; Thüsen JHV; Damhuis RA; Buikhuisen WA; van den Broek EC; Maessen J; Maat APWM; van Schil P; Speel EJM; Dingemans AC
    Endocr Relat Cancer; 2024 Sep; 31(9):. PubMed ID: 38855984
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular Pathology of Gliomas.
    Galbraith K; Snuderl M
    Clin Lab Med; 2024 Jun; 44(2):149-159. PubMed ID: 38821638
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 39.